Bessemer Group Inc. Acquires 2,470 Shares of Koninklijke Philips N.V. $PHG

Bessemer Group Inc. raised its holdings in Koninklijke Philips N.V. (NYSE:PHG) by 125.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,443 shares of the technology company’s stock after acquiring an additional 2,470 shares during the quarter. Bessemer Group Inc.’s holdings in Koninklijke Philips were worth $106,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Fiduciary Management Inc. WI grew its position in shares of Koninklijke Philips by 21.7% during the 1st quarter. Fiduciary Management Inc. WI now owns 7,515,737 shares of the technology company’s stock worth $190,900,000 after buying an additional 1,339,055 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Koninklijke Philips by 2.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company’s stock worth $111,662,000 after buying an additional 106,044 shares in the last quarter. Northern Trust Corp grew its position in shares of Koninklijke Philips by 5.1% during the 1st quarter. Northern Trust Corp now owns 1,690,402 shares of the technology company’s stock worth $42,936,000 after buying an additional 81,653 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Koninklijke Philips by 2.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 1,351,015 shares of the technology company’s stock worth $32,397,000 after buying an additional 32,663 shares in the last quarter. Finally, Perpetual Ltd lifted its stake in shares of Koninklijke Philips by 2.6% during the 2nd quarter. Perpetual Ltd now owns 872,646 shares of the technology company’s stock worth $20,926,000 after purchasing an additional 21,898 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Up 3.0%

Shares of PHG opened at $28.02 on Wednesday. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. Koninklijke Philips N.V. has a 12 month low of $21.48 and a 12 month high of $29.28. The stock’s 50 day moving average is $27.84 and its two-hundred day moving average is $25.80. The firm has a market cap of $26.98 billion, a P/E ratio of 147.45, a PEG ratio of 0.70 and a beta of 0.82.

Koninklijke Philips (NYSE:PHG) last released its earnings results on Tuesday, November 4th. The technology company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%. Analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on PHG shares. Wall Street Zen downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Koninklijke Philips in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.